Ligand Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 6 07:14
Ligand Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 29 07:09
Ligand Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Feb 29 06:54
Ligand Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
May 17, 2023 01:14
Ligand Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
May 11, 2023 07:07
Ligand Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
May 9, 2023 05:12
Ligand Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Oct 3, 2022 21:20
Ligand Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Aug 25, 2022 05:21
Ligand Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Jun 21, 2022 20:00
Ligand Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
May 5, 2022 19:30
Ligand Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Mar 24, 2022 21:09
Ligand Pharmaceuticals | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Mar 24, 2022 05:29
No Data
No Data